541 related articles for article (PubMed ID: 1665051)
1. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
[TBL] [Abstract][Full Text] [Related]
2. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
Blaes F; Beeson D; Plested P; Lang B; Vincent A
Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
[TBL] [Abstract][Full Text] [Related]
3. Seronegative myasthenia gravis.
Vincent A; McConville J; Farrugia ME; Newsom-Davis J
Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
[TBL] [Abstract][Full Text] [Related]
4. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
[TBL] [Abstract][Full Text] [Related]
5. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.
Mittag T; Kornfeld P; Tormay A; Woo C
N Engl J Med; 1976 Mar; 294(13):691-4. PubMed ID: 1250280
[TBL] [Abstract][Full Text] [Related]
6. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
Chan KH; Lachance DH; Harper CM; Lennon VA
Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
[TBL] [Abstract][Full Text] [Related]
7. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
Vernet-der-Garabédian B; Morel E; Bach JF
C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
[TBL] [Abstract][Full Text] [Related]
8. Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture.
Sideris S; Lagoumintzis G; Kordas G; Kostelidou K; Sotiriadis A; Poulas K; Tzartos SJ
J Neuroimmunol; 2007 Sep; 189(1-2):111-7. PubMed ID: 17617475
[TBL] [Abstract][Full Text] [Related]
9. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
Eymard B
Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
[TBL] [Abstract][Full Text] [Related]
11. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
12. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
13. Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line.
Barrett-Jolley R; Byrne N; Vincent A; Newsom-Davis J
Pflugers Arch; 1994 Oct; 428(5-6):492-8. PubMed ID: 7838671
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
[TBL] [Abstract][Full Text] [Related]
15. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.
Zhang B; Tzartos JS; Belimezi M; Ragheb S; Bealmear B; Lewis RA; Xiong WC; Lisak RP; Tzartos SJ; Mei L
Arch Neurol; 2012 Apr; 69(4):445-51. PubMed ID: 22158716
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
Tindall RS
Ann Neurol; 1981 Nov; 10(5):437-47. PubMed ID: 7305297
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
[TBL] [Abstract][Full Text] [Related]
19. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
Vincent A; Newsom-Davis J
Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
